Fighting Cancer With Microbes, Flagship Bets on a $35M Startup

Forbes – November 4, 2015

 

Cancer microbiome play Evelo raises $35M 

BIOCENTURY – NOVember 4, 2015

 

New Startup to Make Bacteria-Based Cancer Treatments 

BIOSCIENCE TECHNOLOGY – NOVember 5, 2015

 

Flagship launches another microbiome biotech with $35M and a focus on cancer

Fierce BioTech – November 4, 2015

 

Flagship launches Evelo with $35M to explore microbiome-based cancer treatments

BioWorld – November 4, 2015

 

Evelo Launches With $35M To Fight Cancer With Cocktails of Bacteria

Xconomy – November 4, 2015

 

Startup aims to harness the microbiome to treat cancer

Boston Globe – November 4, 2015

 

New Startup to Make Bacteria-Based Cancer Treatments

Drug Discovery & Development – November 4, 2015

 

Evelo Therapeutics developing microbiome based cancer therapies

Next Big Future – November 4, 2015

 

Flagship Ventures Launches Evelo Therapeutics With $35M

VENTURE WIRE – NOVEMBER 4, 2015

 

Leveraging the power of the microbiome – a new source for targeted cancer therapy

MEDCITY NEWS – NOVEMBER 4, 2015

 

THE DAILY STARTUP: 3Q A RECORD FOR NETWORKING, SYSTEMS MANAGEMENT, INVESTMENTS

Wall Street Journal – November 4, 2015

 

Startup Evelo Springs Out of Flagship VentureLabs with $35 Million

BIOSPACE – NOVEMBER 4, 2015

 

Flagship launches another microbiome biotech with $35M and a focus on cancer

BIOTECNIKA.ORG – NOVEMBER 5, 2015

 

Evelo Therapeutics Seeks To Disrupt Cancer Enabling Effects of Microbiome

MEDICAL RESEARCH – NOVEMBER 4, 2015

 

HOME